Search - tctmd.com

Displaying 561 - 580 of 901

Sort: Relevancy | Date

Presentation TVT 2017

Potential Regulatory Pathways for Transcatheter Tricuspid Interventions

Presenter: Gregg W. Stone, Michael J. Mack

June 15, 2017

News Conference News TVT 2017

Mitral Valve Repair Technologies Inch Forward, but Question of Combination Therapy Looms

Shelley Wood

June 15, 2017

No Very Late Scaffold Thrombosis Risk With Absorb BVS in China, Japan

News Conference News EuroPCR 2017

No Very Late Scaffold Thrombosis Risk With Absorb BVS Studies in China, Japan

Michael O'Riordan

May 17, 2017

News Conference News EuroPCR 2017

DESSOLVE III: MiStent Holds Up Well Against Xience at 12 Months, Hints at Potential Longer-Term Benefit

Michael O'Riordan

May 16, 2017

News Features

Absorb in Europe: When, How, and by Whom the Beleaguered BVS Is Being Used After Restrictions

Michael O'Riordan

May 08, 2017

News Industry News

LivaNova Acquires Caisson Interventional, LLC

May 02, 2017

News Conference News EAS 2017

EAS Consensus Document Strives to Banish Skepticism Over LDL Cholesterol’s Causal Role in Atherosclerosis

Yael L. Maxwell

April 24, 2017

News Daily News

Absorb BVS Use Restricted in Europe

Michael O'Riordan

April 06, 2017

News Daily News

Looking Beyond Randomized Trials: Could a Wider Range of Studies Support Device Approval?

Todd Neale

April 05, 2017

News Conference News ACC 2017

SPIRE 1 and 2: Support for PCSK9 Inhibition but Not Bococizumab

Yael L. Maxwell

March 17, 2017

News Daily News

Herbals and the Heart: New Review Seeks to Sum Up Dearth of Data on Effects and Hazards

Shelley Wood

February 28, 2017

News Daily News

Less Acute MI, More HF: European Task Force Shifts Support for ‘Overhyped’ Cell Therapy Research

Yael L. Maxwell

February 22, 2017

News Industry News

Micro Medical Solutions Receives CE Mark Approval for MicroStent

February 14, 2017

News Conference News ISET 2017

Positive 6-Month Outcomes Seen With Endovascular Therapy for Symptomatic PAD: LIBERTY 360

Caitlin E. Cox

February 07, 2017

News Daily News

NeuroARC Proposes New Standards for Assessing Neurologic Damage in CV Clinical Trials

Caitlin E. Cox

February 07, 2017

News Conference News ISET 2017

Forging Into the Future: Debating the Merits of TAVR in Younger, Futile, and Lower-Risk Patients

Caitlin E. Cox

February 06, 2017

News Daily News

Pregnancy Confers Unique Risk of Cardiovascular Disease, Two New Studies Suggest

Yael L. Maxwell

February 02, 2017

News Industry News

Abbott Announces U.S. Approval for Its Assurity MRI™ Pacemaker, The World’s Smallest, Longest-Lasting Wirelless MRI-Compatible Pacemaker

February 01, 2017

News Features

The Prickly Problem of Permanent Pacing After TAVR: One Hospital Pitches a Protocol

Michael O'Riordan

January 24, 2017

News Daily News

TWENTE: Resolute and Xience Stents Show Comparable Outcomes up to 5 Years

Michael O'Riordan

January 20, 2017

Advertisement

Potential Regulatory Pathways for Transcatheter Tricuspid Interventions

Mitral Valve Repair Technologies Inch Forward, but Question of Combination Therapy Looms

No Very Late Scaffold Thrombosis Risk With Absorb BVS Studies in China, Japan

DESSOLVE III: MiStent Holds Up Well Against Xience at 12 Months, Hints at Potential Longer-Term Benefit

Absorb in Europe: When, How, and by Whom the Beleaguered BVS Is Being Used After Restrictions

LivaNova Acquires Caisson Interventional, LLC

EAS Consensus Document Strives to Banish Skepticism Over LDL Cholesterol’s Causal Role in Atherosclerosis

Absorb BVS Use Restricted in Europe

Looking Beyond Randomized Trials: Could a Wider Range of Studies Support Device Approval?

SPIRE 1 and 2: Support for PCSK9 Inhibition but Not Bococizumab

Herbals and the Heart: New Review Seeks to Sum Up Dearth of Data on Effects and Hazards

Less Acute MI, More HF: European Task Force Shifts Support for ‘Overhyped’ Cell Therapy Research

Micro Medical Solutions Receives CE Mark Approval for MicroStent

Positive 6-Month Outcomes Seen With Endovascular Therapy for Symptomatic PAD: LIBERTY 360

NeuroARC Proposes New Standards for Assessing Neurologic Damage in CV Clinical Trials

Forging Into the Future: Debating the Merits of TAVR in Younger, Futile, and Lower-Risk Patients

Pregnancy Confers Unique Risk of Cardiovascular Disease, Two New Studies Suggest

Abbott Announces U.S. Approval for Its Assurity MRI™ Pacemaker, The World’s Smallest, Longest-Lasting Wirelless MRI-Compatible Pacemaker

The Prickly Problem of Permanent Pacing After TAVR: One Hospital Pitches a Protocol

TWENTE: Resolute and Xience Stents Show Comparable Outcomes up to 5 Years

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content